Background COVID-19 vaccines show excellent efficacy in clinical trials and effectiveness
in real-world data, but some people still become infected with SARS-CoV-2 after vaccination. …

Background The SARS-CoV-2 variant of concern, omicron, appears to be less severe than
delta. We aim to quantify the differences in symptom prevalence, risk of hospital admission, …

Background Cognitive impairment has been reported after many types of infection, including
SARS-CoV-2. Whether deficits following SARS-CoV-2 improve over time is unclear. Studies …

The Delta (B.1.617.2) variant was the predominant UK circulating SARS-CoV-2 strain
between May and December 2021. How Delta infection compares with previous variants is …

Background Self-reported symptom studies rapidly increased understanding of SARS-CoV-2
during the COVID-19 pandemic and enabled monitoring of long-term effects of COVID-19 …

Background The need for a fast and reliable test for COVID-19 is paramount in managing the
current pandemic. A cost effective and efficient diagnostic tool as near to the point of care (…

Background Self-reported symptom studies rapidly increased our understanding of SARS-CoV-2
during the pandemic and enabled the monitoring of long-term effects of COVID-19 …

Background A cost effective and efficient diagnostic tool for COVID-19 as near to the point of
care (PoC) as possible would be a game changer in the current pandemic. We tested …

Background Identifying and testing individuals likely to have SARS-CoV-2 is critical for
infection control, including post-vaccination. Vaccination is a major public health strategy to …

This study assessed T‐cell responses in individuals with and without a positive antibody
response to SARS‐CoV‐2, in symptomatic and asymptomatic individuals during the COVID‐19 …